Energy dissimilation characteristics and shock mechanism of coal-rock mass induced in steeply-inclined mining: comparison based on physical simulation and numerical calculation
Acta Geotechnica · 2023-02 · 18 (2) · 843-864
DOI: 10.1007/s11440-022-01617-2 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Geotechnica, online erschienen am 25.07.2022. Verfasst von Huicong Xu und 7 weiteren Autor:innen. Die Arbeit wurde bisher 124-mal zitiert (Crossref) und nennt 30 Literaturangaben. Gefördert von: the basic research program of Natural Science in Shaanxi Province, National Natural Science Foundation of China, the Key Research and Development Program of Shaanxi Province.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- the basic research program of Natural Science in Shaanxi Province
- National Natural Science Foundation of China
- the Key Research and Development Program of Shaanxi Province
Zitieren
APA
Xu, H., Lai, X., Shan, P., Yang, Y., Zhang, S., Yan, B., Zhang, Y., & Zhang, N. (2023). Energy dissimilation characteristics and shock mechanism of coal-rock mass induced in steeply-inclined mining: comparison based on physical simulation and numerical calculation. Acta Geotechnica, 18(2), 843-864. https://doi.org/10.1007/s11440-022-01617-2
Vancouver
Xu H, Lai X, Shan P, Yang Y, Zhang S, Yan B, et al. Energy dissimilation characteristics and shock mechanism of coal-rock mass induced in steeply-inclined mining: comparison based on physical simulation and numerical calculation. Acta Geotechnica. 2023;18(2):843-864. doi:10.1007/s11440-022-01617-2
BibTeX
@article{Xu2023,
author = {Xu, Huicong and Lai, Xingping and Shan, Pengfei and Yang, Yanbin and Zhang, Shuai and Yan, Baoxu and Zhang, Yun and Zhang, Nan},
title = {Energy dissimilation characteristics and shock mechanism of coal-rock mass induced in steeply-inclined mining: comparison based on physical simulation and numerical calculation},
journal = {Acta Geotechnica},
year = {2023},
volume = {18},
number = {2},
pages = {843--864},
doi = {10.1007/s11440-022-01617-2}
}
EUVIMED